ZYXI
NASDAQZynex Inc.
SectorHealth CareIndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
Website
News25/Ratings10
News · 26 weeks110%
2025-10-262026-04-19
Mix090d
No activity.
Latest news
25 items- SECZynex Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - ZYNEX INC (0000846475) (Filer)
- SECZynex Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - ZYNEX INC (0000846475) (Filer)
- PRZynex Financial Restructuring Puts Company on Path to Long-Term SuccessENGLEWOOD, Colo., Dec. 16, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management and rehabilitation today announced it has voluntarily entered into a Chapter 11 court-supervised financial restructuring with the support of new financing from the Company's lenders. "Today we take the next step in creating a new future for Zynex," said Steven Dyson, Chief Executive Officer. "This financing demonstrates the confidence our lenders have in our business and
- INSIDERSEC Form 3 filed by new insider Aronzon Paul3 - ZYNEX INC (0000846475) (Issuer)
- SECSEC Form 10-Q filed by Zynex Inc.10-Q - ZYNEX INC (0000846475) (Filer)
- SECZynex Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ZYNEX INC (0000846475) (Filer)
- PRZynex Reports Third Quarter 2025 Financial ResultsENGLEWOOD, Colo., Nov. 17, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, and rehabilitation, today reported its financial and operational results for the third quarter ended September 30, 2025. Management Commentary and Recent Events "Since joining the Company in August, the new management team has worked tirelessly to address the business and compliance challenges at Zynex while creating a new future for all our company," said Steven Dyson,
- PRZynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special CommitteeENGLEWOOD, Colo., Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management and rehabilitation, today announced a series of strategic initiatives aimed at positioning Zynex for long-term success. Zynex has engaged Province, LLC, an internationally recognized financial advisory firm, to assist on evaluating a range of strategic alternatives, including potential capital raising opportunities and recapitalization and restructuring strategies. In add
- PRZynex Sets Third Quarter 2025 Earnings CallENGLEWOOD, Colo., Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management and rehabilitation, will hold a conference call on Tuesday, November 18, 2025 at 9:00 AM Eastern Time to discuss its financial results for the third quarter ended September 30, 2025. Financial results will be issued in a press release prior to the call. Zynex management will host the conference call. Date: Tuesday, November 18, 2025Time: 9:00 AM Eastern Time (7:00 PM Moun
- SECSEC Form NT 10-Q filed by Zynex Inc.NT 10-Q - ZYNEX INC (0000846475) (Filer)
- SECZynex Inc. filed SEC Form 8-K: Leadership Update8-K - ZYNEX INC (0000846475) (Filer)
- INSIDERSEC Form 3 filed by new insider Wise Bret W3 - ZYNEX INC (0000846475) (Issuer)
- PRZynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee ChairENGLEWOOD, Colo., Oct. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of Bret Wise to its Board of Directors. Mr. Wise will also serve as Chair of the Audit Committee. "Bret Wise is a great addition to our Board of Directors as the Chair of our Audit Committee as we continue to refocus the Zynex mission and vision around patient and customer success with a renewed comm
- SECZynex Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - ZYNEX INC (0000846475) (Filer)
- SECZynex Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Material Impairments8-K - ZYNEX INC (0000846475) (Filer)
- SECZynex Inc. filed SEC Form 8-K: Leadership Update8-K - ZYNEX INC (0000846475) (Filer)
- INSIDERSEC Form 3 filed by new insider Bajaj Vikram Singh3 - ZYNEX INC (0000846475) (Issuer)
- INSIDERSEC Form 3 filed by new insider Dyson Steven Lewis3 - ZYNEX INC (0000846475) (Issuer)
- INSIDERSEC Form 3 filed by new insider Bibb John T3 - ZYNEX INC (0000846475) (Issuer)
- SECZynex Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - ZYNEX INC (0000846475) (Filer)
- PRZynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key RolesENGLEWOOD, Colo., Aug. 18, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the arrival of newly appointed CEO, Steven Dyson, and the appointment of several new leaders at the Company. On June 30, 2025, the Company announced the Board's appointment of Steven Dyson as the incoming CEO. Since that time, Mr. Dyson and Thomas Sandgaard, the Chairman of the Board, have been actively working wi
- ANALYSTZynex upgraded by Ladenburg Thalmann with a new price targetLadenburg Thalmann upgraded Zynex from Neutral to Buy and set a new price target of $3.70
- ANALYSTZynex downgraded by H.C. WainwrightH.C. Wainwright downgraded Zynex from Buy to Neutral
- SECSEC Form 10-Q filed by Zynex Inc.10-Q - ZYNEX INC (0000846475) (Filer)
- SECZynex Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ZYNEX INC (0000846475) (Filer)